NCT05765201View on ClinicalTrials.gov

Phacoemulsification at High IOP and Physiologic IOP: Impact on Anterior and Posterior Segment Physiology

CompletedOBSERVATIONAL
Enrollment

27

Participants

Timeline

Start Date

September 22, 2022

Primary Completion Date

May 4, 2023

Study Completion Date

May 4, 2023

Conditions
Nuclear Cataract
Interventions
OTHER

High IOP

Prospective, single-surgeon, randomized, paired-eye study; patients undergoing sequential, uncomplicated bilateral phacoemulsification using Active Sentry handpiece® with intraocular IOP ≤ 28mmHg (low IOP) in one eye and with IOP ≥ 60mmHg (high IOP) in the other eye

OTHER

Low IOP

Prospective, single-surgeon, randomized, paired-eye study; patients undergoing sequential, uncomplicated bilateral phacoemulsification using Active Sentry handpiece® with intraocular IOP ≤ 28mmHg (low IOP) in one eye and with IOP ≥ 60mmHg (high IOP) in the other eye

Trial Locations (1)

50266

Wolfe Eye Clinic, West Des Moines

All Listed Sponsors
lead

Matthew Rauen

OTHER